374 related articles for article (PubMed ID: 35720407)
1. The Love-Hate Relationship Between TGF-β Signaling and the Immune System During Development and Tumorigenesis.
Chen B; Mu C; Zhang Z; He X; Liu X
Front Immunol; 2022; 13():891268. PubMed ID: 35720407
[TBL] [Abstract][Full Text] [Related]
2. Blockade of TGF-β signaling: a potential target for cancer immunotherapy?
Ungefroren H
Expert Opin Ther Targets; 2019 Aug; 23(8):679-693. PubMed ID: 31232607
[No Abstract] [Full Text] [Related]
3. TGF-β and Cancer Immunotherapy.
MaruYama T; Chen W; Shibata H
Biol Pharm Bull; 2022; 45(2):155-161. PubMed ID: 35110501
[TBL] [Abstract][Full Text] [Related]
4. Transforming Growth Factor-β Signaling in Immunity and Cancer.
Batlle E; Massagué J
Immunity; 2019 Apr; 50(4):924-940. PubMed ID: 30995507
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta: a master immune regulator.
Larson C; Oronsky B; Carter CA; Oronsky A; Knox SJ; Sher D; Reid TR
Expert Opin Ther Targets; 2020 May; 24(5):427-438. PubMed ID: 32228232
[No Abstract] [Full Text] [Related]
6. The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cells.
Quatromoni JG; Suzuki E; Okusanya O; Judy BF; Bhojnagarwala P; Venegas O; Eruslanov E; Predina JD; Albelda SM; Singhal S
BMC Immunol; 2013 Jul; 14():30. PubMed ID: 23865808
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy.
Zhang L; Yu Z; Muranski P; Palmer DC; Restifo NP; Rosenberg SA; Morgan RA
Gene Ther; 2013 May; 20(5):575-80. PubMed ID: 22972494
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression.
van den Bulk J; de Miranda NFCC; Ten Dijke P
Clin Sci (Lond); 2021 Jan; 135(1):35-52. PubMed ID: 33399850
[TBL] [Abstract][Full Text] [Related]
9. Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy.
Zhao H; Wei J; Sun J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107101. PubMed ID: 33099067
[TBL] [Abstract][Full Text] [Related]
10. Dichotomous roles of TGF-β in human cancer.
Huang JJ; Blobe GC
Biochem Soc Trans; 2016 Oct; 44(5):1441-1454. PubMed ID: 27911726
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.
Yang L; Pang Y; Moses HL
Trends Immunol; 2010 Jun; 31(6):220-7. PubMed ID: 20538542
[TBL] [Abstract][Full Text] [Related]
12. TGF-β: guardian of T cell function.
Oh SA; Li MO
J Immunol; 2013 Oct; 191(8):3973-9. PubMed ID: 24098055
[TBL] [Abstract][Full Text] [Related]
13. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
[TBL] [Abstract][Full Text] [Related]
14. Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8
Zhang Q; Helfand BT; Carneiro BA; Qin W; Yang XJ; Lee C; Zhang W; Giles FJ; Cristofanilli M; Kuzel TM
Eur Urol; 2018 May; 73(5):648-652. PubMed ID: 29275833
[TBL] [Abstract][Full Text] [Related]
15. Effects of TGF-beta on the immune system: implications for cancer immunotherapy.
de Visser KE; Kast WM
Leukemia; 1999 Aug; 13(8):1188-99. PubMed ID: 10450746
[TBL] [Abstract][Full Text] [Related]
16. Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma.
Kondo Y; Suzuki S; Takahara T; Ono S; Goto M; Miyabe S; Sugita Y; Ogawa T; Ito H; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
Cancer Sci; 2021 Oct; 112(10):4037-4049. PubMed ID: 34309966
[TBL] [Abstract][Full Text] [Related]
17. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy via targeted TGF-β signalling blockade in T
Li S; Liu M; Do MH; Chou C; Stamatiades EG; Nixon BG; Shi W; Zhang X; Li P; Gao S; Capistrano KJ; Xu H; Cheung NV; Li MO
Nature; 2020 Nov; 587(7832):121-125. PubMed ID: 33087933
[TBL] [Abstract][Full Text] [Related]
20. From TGF-beta to cancer therapy.
Huang X; Lee C
Curr Drug Targets; 2003 Apr; 4(3):243-50. PubMed ID: 12643474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
